Long-term outcome of 25 children and adolescents with severe aplastic anemia treated with antithymocyte globulin

Brazilian Journal of Medical and Biological Research

Volumn 33, Issue 5, 2000, Pages 553-558

  De Medeiros, C R ^a   Ribeiro, R C ^b   Bittencourt, M A ^a   Zanis Neto, J ^a   Pasquini, R ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Adolescents; Antithymocyte globulin; Aplastic anemia; Children

Indexed keywords

THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FEVER; HUMAN; LEUKOCYTE COUNT; MALE; RASH; THROMBOCYTOPENIA; TREATMENT OUTCOME; TRISOMY 8; VASCULITIS;

EQUIDAE;

EID: 0034120116     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2000000500010     Document Type: Article

References (26)

1. Young NS & Alter BP (1994). Definitive treatment of acquired aplastic aremia. In: Young NS & Alter BP (Editors). Aplastic Anemia: Acquired and Inherited. 1st edn. W.B. Saunders Company, Philadelphia, PA.
2. Maciejewski JP, Selleri C, Sato T, Anderson S & Young NS (1996) A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. Blood, 88: 1983-1991.
3. Marsh JC, Chang J, Testa NG, Hows JM & Dexter TM (1991). In vitro assessment of marrow 'stem cell' and stromal cell function in aplastic anaemia. British Journal of Haematology, 78: 258-267.
4. Champlin RE, Feig SA, Sparkes RS & Gale RP (1984). Bone marrow transplantation from identical twins in the treatment of aplastic anaemia: implicaton for the pathogenesis of the disease British Journal of Haematology, 56: 455-463.
5. Hinterberger W, Bowlings PA, Hinterberger-Fischer M, Gibson J, Jacobsen N & Klein JP (1997). Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Annals of Internal Medicine, 126: 116-122.
6. Young NS & Maciejewski J (1997). Mechanism of disease: the pathophysiology of acquired aplastic anemia. New England Journal of Medicine, 336: 1365-1372.
7. Mathé G, Amiel JL & Schwarzenberg L (1970). Bone marrow graft in man after conditioning by antilymphocytic serum. British Medical Journal, 2: 131-136.
8. Champlin RE, Ho WG & Gale RP (1983). Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. New England Journal of Medicine, 308: 113-118.
9. Young NS, Griffith P, Brittain E, Elfenbein G, Gardner F, Huang A, Harmon D, Hewllet J, Fay J, Mangan K, Morrison F, Sensebrenner L, Shadduck R, Wang W, Zarouilis C & Zuckerman K (1998). A multicentric trial of antithymocyte globulin therapy for aplastic anemia and related diseases Blood, 72: 1861-1869.
10. Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, Van Lint MT, Congiu M, De Planque MM, Ernst P, McCann S, Raghavachar A, Frickhofen N, Wursch A, Marmont AM & Gordon-Smith EC (1988). Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA Working Party. British Journal of Haematology. 70: 177-182.
11. Socie G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P. McCann SR, Frickhofen N, Van Veer-Korthof E & Gluckman E for the European Bone Marrow Transplantation Severe Aplastic Anema Working Party (11993). Malignant tumors occurring after treatment of aplastic anemia. New England Journal of Medicine, 329: 1152-1157.
12. De Planque MM, Klum-Nelemans HC, van Krieken HJ, Kluin PM, Brand A, Beverstock JC, Willenze R & Van Rood JJ (1988). Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults. British Journal of Haematology, 70: 55-62.
13. Tichelli A, Gratwohl A, Wursch A, Nissen C & Speck B (1988). Late haematological complications in severe aplastic anaemia. British Journal of Haematology, 69: 413-420.
14. Raquette RL, Tebyani N, Frane M, Ireland P, Ho WG, Champlin RE & Nimer SD (1995). Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone mar-row transplantation. Blood, 85: 283-290.
15. Geary CG, Harrison CJ, Philpott NJ, Hows JM, Gordon-Smith EC & Marsh JCW (1999). Abnormal cytogenetic clones in patients with aplastic anemia: response to immunosuppressive therapy. British Journal of Haematology, 104: 271-274.
16. Doney K, Pepe M, Storb R, Bryant E, Anasetti C, Appelbaum FR, Buckner CD, Sanders J, Singer J, Sullivan K, Weiden P & Hansen J (1992). Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone. Blood, 79: 2566-2571.
17. Speck B, Tichelli A, Gratwohl A & Nissen C (1990). Treatment of severe aplastic anemia: a 12 year follow-up of patients after bone marrow transplantation or after therapy with antilymphocyte globulin. In: Sahid NT (Editor), Aplastic Anemia and Other Bone Marrow Failure Syndromes. Springer-Verlag, New York, NY.
18. Ohara A, Kojima S & Hamajima N (1997). Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood, 90: 1009-1012.
19. Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, Locatelli F, Mori PG, Saracco P, Todeschini G, Coser P, Iacopino P, Van Lint MT & Gluckman E for the European Group for Blood and Marrow Transplantation Working Party on SAA (1995). Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood, 85: 1348-1353.
20. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Hermann F, Freund M, Meusers P, Salama A & Heimpel H (1991). Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. New England Journal of Medicine, 324: 1297-1304.
21. Schrezenmeier H, Marin P, Raghavachar A, McCann S, Hows J, Gluckman E, Nissen C, Van Veer-Korthof ET, Ljungman P, Hinterberger W, Van Lint MT, Frickhofen N & Bacigalupo A (1992). Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party. British Journal of Haematology, 85: 371-379.
22. Gluckman E, Esperou-Bourdeau H, Baruchel A, Boogaerts M, Briere J, Donadio D, Leverger G, Leporrier M, Reiffers J, Janvier M, Michallet M, Strickmans P & The Cooperative Group on the Treatment of Aplastic Anemia (1992). Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. Blood, 79: 2540-2546.
23. Bayever E, Champlin R & Ho W (1982). Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia. Journal of Pediatrics, 100: 307-316.
24. Halperin DS, Grisaru D, Freedman MH & Saunders EF (1988). Severe acquired aplastic anemia in children: 11-year experience with bone marrow transplantation and immunosuppressive therapy. American Journal of Pediatric Hematology and Oncology, 11: 304-311.
25. Gillo A, Boulad F, Small T, Kernan N, Reyes B, Childs B, Castro-Malaspina H & O'Reilly RJ (1993). Treatment of severe aplastic anemia in children: the MSKCC experience. Blood, 82 693 (Abstract).
26. Bittencourt MA, Medeiros CR, Zanis-Neto J, Andrade RJ, Ogasawara VS, Friedrich MLK, Bonfim CMS, Ribeiro RC & Pasquini R (1995). Prednisone and cyclospoorine for severe acquired anemia: 101 cases treated at a single institution. Blood, 86: 1893 (Abstract).